Benzinga | Feb 18, 2021 05:32AM EST

Needham Initiates Coverage On Generation Bio with Buy Rating, Announces Price Target of $50

Needham analyst Gil Blum initiates coverage on Generation Bio (NASDAQ:GBIO) with a Buy rating and announces Price Target of $50.